Quest Pharmaceutical Services, LLC, a GLP-compliant CRO providing testing services to support preclinical and clinical research and development, has formally changed its name to QPS, LLC.

The company commissioned independent market research to evaluate the pharmaceutical research industry’s recognition and perception of both the Quest Pharmaceutical Services and QPS names. The name change “supports the company’s mission to provide meticulous quality, performance driven by an adherence to client timelines and impeccable client service,” according to a company statement.

Founded in 1995, QPS has bioanalytical and DMPK facilities at its Newark, DE headquarters and a bioanalytical laboratory in Taipei, Taiwan. Regional sales offices are maintained in Boston, Connecticut, Pennsylvania, California, New Jersey, and Texas.